Sanofi is a French pharmaceutical company created in 2004 by the merger of Sanofi-Synthรฉlabo and Aventis. With sales of EUR 36.1 billion in 2019 and more than 100,000 employees worldwide, Sanofi is one of the largest pharmaceutical companies in the world in terms of sales.
According to Sanofi's latest financial reports and stock price the company's current Operating Margin is 15.12%. At the end of 2024 the company had an Operating Margin of 15.12%.
Year | Operating Margin | Change |
---|---|---|
2024 | 15.12% | 0.7% |
2023 | 15.02% | -38.69% |
2022 | 24.50% | 23.08% |
2021 | 19.91% | -46.01% |
2020 | 36.87% | 404.16% |
2019 | 7.31% | -40.77% |
2018 | 12.35% | -19.14% |
2017 | 15.27% | -6.64% |
2016 | 16.36% | 8.75% |
2015 | 15.04% | -14.94% |
2014 | 17.68% | 23.39% |
2013 | 14.33% | -10.73% |
2012 | 16.05% | 7.05% |
2011 | 15.00% | -17.32% |
2010 | 18.14% | -8.06% |
2009 | 19.73% | 36.59% |
2008 | 14.44% | -26.92% |
2007 | 19.76% | 22.75% |
2006 | 16.10% | 73.68% |
2005 | 9.27% | -36.88% |
2004 | 14.69% | -62.28% |
2003 | 38.94% | 15.79% |
2002 | 33.63% | 1.96% |
2001 | 32.98% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
![]() Merck MRK | 31.06% | 105.42% | ๐บ๐ธ USA |
![]() Pfizer PFE | 12.60% | -16.67% | ๐บ๐ธ USA |
![]() Bristol-Myers Squibb BMY | 12.82% | -15.21% | ๐บ๐ธ USA |
![]() Novartis NVS | 28.02% | 85.32% | ๐จ๐ญ Switzerland |
![]() GlaxoSmithKline GSK | 13.32% | -11.90% | ๐ฌ๐ง UK |
![]() Teva Pharmaceutical Industries TEVA | -7.76% | -151.32% | ๐ฎ๐ฑ Israel |
![]() Johnson & Johnson JNJ | 18.78% | 24.21% | ๐บ๐ธ USA |
![]() Eli Lilly LLY | 27.75% | 83.53% | ๐บ๐ธ USA |
![]() Novo Nordisk NVO | 43.79% | 189.62% | ๐ฉ๐ฐ Denmark |
![]() Abbott Laboratories ABT | 17.36% | 14.81% | ๐บ๐ธ USA |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.